Choosing Life with Spinal Muscular Atrophy Type 1

被引:0
|
作者
Moran Lavie
Hodaya Nisnkorn
Liora Sagi
Israel Amirav
机构
[1] Tel Aviv University,Pediatric Pulmonology Unit, Dana
[2] Tel Aviv University,Dwek Children’s Hospital, Tel
来源
Advances in Therapy | 2020年 / 37卷
关键词
Antisense oligonucleotide; Intrathecal injections; Motor neuron disease; Nusinersen; Spinal muscular atrophy;
D O I
暂无
中图分类号
学科分类号
摘要
This article is co-authored by the mother of a patient with spinal muscular atrophy (SMA), two pediatric pulmonologists and the pediatric neurologist in the team. It describes the patient and their family’s experience of living with SMA. This commentary describes the mother’s experience of the diagnosis and treatment process of her daughter’s SMA in an era of emerging treatments for a disease which was until recently considered incurable. SMA diagnosis and management in the context of the patient mother’s experiences is discussed.
引用
收藏
页码:1708 / 1713
页数:5
相关论文
共 50 条
  • [1] Choosing Life with Spinal Muscular Atrophy Type 1
    Lavie, Moran
    Nisnkorn, Hodaya
    Sagi, Liora
    Amirav, Israel
    ADVANCES IN THERAPY, 2020, 37 (05) : 1708 - 1713
  • [2] Spinal muscular atrophy type 1 quality of life
    Bach, JR
    Vega, J
    Majors, J
    Friedman, A
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2003, 82 (02) : 137 - 142
  • [3] Risdiplam in Type 1 Spinal Muscular Atrophy
    Baranello, Giovanni
    Darras, Basil T.
    Day, John W.
    Deconinck, Nicolas
    Klein, Andrea
    Masson, Riccardo
    Mercuri, Eugenio
    Rose, Kristy
    El-Khairi, Muna
    Gerber, Marianne
    Gorni, Ksenija
    Khwaja, Omar
    Kletzl, Heidemarie
    Scalco, Renata S.
    Seabrook, Timothy
    Fontoura, Paulo
    Servais, Laurent
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (10): : 915 - 923
  • [4] Risdiplam in Type 1 Spinal Muscular Atrophy
    Krandick, Guido
    MONATSSCHRIFT KINDERHEILKUNDE, 2021, 169 (11) : 995 - 997
  • [5] Genetic therapies for spinal muscular atrophy type 1
    Aartsma-Rus, Annemieke
    LANCET NEUROLOGY, 2018, 17 (02): : 111 - 112
  • [6] General movements in spinal muscular atrophy type 1
    Kahraman, Aysu
    Mutlu, Akmer
    Livanelioglu, Ayse
    PHYSIOTHERAPY THEORY AND PRACTICE, 2024, 40 (06) : 1249 - 1255
  • [7] CHILD WITH SPINAL MUSCULAR ATROPHY TYPE 1 AND POLYNEUROPATHY
    Leiva Pemberthy, Luz Miriam
    Espinosa, Katalina
    Eugenia Zuluaga, Maria
    MUSCLE & NERVE, 2021, 64 : S42 - S42
  • [8] SPINAL MUSCULAR ATROPHY TYPE 1: ESTIMATION OF SURVIVAL
    Ribero, Aponte, V
    Sutherland, C. S.
    Gorni, K.
    Mitchell, S.
    Batson, S.
    VALUE IN HEALTH, 2020, 23 : S636 - S637
  • [9] Survival of Patients With Spinal Muscular Atrophy Type 1
    Gregoretti, Cesare
    Ottonello, Giancarlo
    Testa, Maria Beatrice Chiarini
    Mastella, Chiara
    Rava, Lucilla
    Bignamini, Elisabetta
    Veljkovic, Aleksandar
    Cutrera, Renato
    PEDIATRICS, 2013, 131 (05) : E1509 - E1514
  • [10] Spinal muscular atrophy type 1: Management and outcomes
    Bach, JR
    Baird, JS
    Plosky, D
    Navado, J
    Weaver, B
    PEDIATRIC PULMONOLOGY, 2002, 34 (01) : 16 - 22